Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. Issue 2 (February 2017) - Haghikia, Aiden; Dendrou, Calliope A; Schneider, Ruth; Grüter, Thomas; Postert, Thomas; Matzke, Mike; Stephanik, Heike; Fugger, Lars; Gold, Ralf